JAMA Cardiology Review Time

JAMA Cardiology's official about page is unusually useful. It tells authors directly that the median is 8 days without peer review and 51 days with peer review.

That split matters because it reveals the journal's operating logic:

• the front door is a triage system, not just an administrative step
• reviewed papers get a more normal cardiology-journal timeline
• the journal knows very early whether the manuscript is broad enough for its readership

What the official page does not tell you is how often timing pain is really positioning pain. A good cardiology paper can still be a bad JAMA Cardiology paper if the consequence is too narrow.

That is the cleanest planning model. The journal is fast at deciding whether your manuscript belongs, then more normal once it commits reviewer time.

JAMA Cardiology has a very clear editorial identity. Editors can reject quickly when a paper is:

• too subspecialty-specific for a broad clinical-cardiology readership
• technically sound but weak on practice consequence
• methodologically interesting without a visible patient-care implication
• more naturally suited to JACC, Circulation, or a narrower specialty venue
• framed around prestige rather than a concrete clinical question

That is why the 8-day desk number is credible. The journal is not searching slowly for fit. It is testing practice relevance immediately.

The slower papers are usually not obvious rejects. They are the papers close enough to argue about.

The common causes are:

• reviewer concern about whether the result really changes management
• questions about generalizability, endpoint choice, or analytic discipline
• debate over whether the manuscript is broad cardiology or still subspecialty-first
• revisions that improve wording but still leave the clinical consequence underpowered
• tension between statistical rigor and the strength of the headline claim

When JAMA Cardiology feels slow, it is usually because the journal thinks the paper might matter, but only if the evidence and framing become harder to dispute.

JAMA Cardiology is down from 14.7 in 2023 to 14.1 in 2024, which is best read as normalization after the COVID-era citation spike rather than a sign of weakening editorial leverage. The journal still has enough status to reject quickly and still demand broad clinical relevance.

For review time, that matters because the journal does not need to widen its audience to hold position. It can keep the front-end screen sharp.

Even with this good official split, a few things stay hidden:

• the 8-day number is mostly a triage number, not a peer-review number
• 51 days with review still says nothing about whether the eventual revision will be easy
• timing does not tell you whether the paper is clinically broad enough
• a fast no can still reflect a correct venue judgment, not weak science

So the numbers are useful, but they only make sense if paired with the journal's audience standard.

In our pre-submission review work, the biggest timing mistake is treating JAMA Cardiology like a prestige upgrade for a narrow cardiology paper. The journal usually detects that fast.

The manuscripts that move best tend to have:

• a clinical question legible to general cardiology readers
• a main figure or table that makes the practical consequence visible quickly
• analytic discipline strong enough to survive skeptical review
• a cover letter that argues readership fit rather than brand aspiration

Those traits let the fast desk screen work for the paper instead of against it.

For JAMA Cardiology, timing matters less than broad clinical consequence. The better question is whether the manuscript already behaves like a JAMA Cardiology paper.

That is why the better next reads are:

• JAMA Cardiology journal profile
• JAMA Cardiology submission guide
• JAMA Cardiology submission process
• JAMA Cardiology cover letter guide

A JAMA Cardiology practice-relevance check is usually more useful than trying to optimize around the 8-day desk number.

JAMA Cardiology review time is fast because the journal knows what it wants. The official split between desk decisions and reviewed decisions is real and helpful. If the paper belongs in broad clinical cardiology, the process can move efficiently. If not, the speed mostly delivers an early answer.